Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ: GLMD · Real-Time Price · USD

0.5931

-0.0088 (-1.46%)

At close: Aug 10, 2026, 4:00 PM EDT

0.5862

-0.0069 (-1.16%)

After-hours: Aug 10, 2026, 6:20 PM EDT

Galmed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.6	3.99	4.65	2.86	2.02	2.88
Short-Term Investments	13.85	14.17	10.68	9.78	11.77	31.93
Cash & Short-Term Investments	15.45	18.16	15.33	12.64	13.79	34.82
Cash Growth	-1.77%	18.43%	21.27%	-8.29%	-60.41%	-31.58%
Other Receivables	0.45	0.35	0.67	0.48	0.83	1.13
Total Trade Receivables	0.45	0.35	0.67	0.48	0.83	1.13
Other Current Assets	0.13	0.12	0.12	0.12	0.11	0.11
Total Current Assets	16.03	18.63	16.12	13.24	14.72	36.05
Net Property, Plant & Equipment	-	-	-	0.13	0.34	0.55
Long-Term Investments	-	-	2.12	3.27	1.5	-
Other Long-Term Assets	-	-	0.26	-	-	-
Total Assets	16.03	18.63	18.5	16.63	16.56	36.61

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.72	2	1.31	1.88	2.56	4.87
Accrued Expenses	0.36	0.84	0.87	0.87	0.53	1.01
Total Current Liabilities	2.08	2.85	2.17	2.75	3.09	5.88
Total Liabilities	2.08	2.85	2.17	2.75	3.09	5.88

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	3.42	3.41	0.74	0.21	0.07	0.07
Additional Paid-in Capital	223.6	223.46	216.47	207.08	200.14	198.77
Accumulated Other Comprehensive Income	-0.38	-0.3	-0.42	-0.45	-0.75	-0.17
Retained Earnings	-212.69	-210.78	-200.47	-192.95	-186.04	-168.17
Shareholders' Equity	13.95	15.78	16.33	13.88	13.42	30.5
Total Liabilities & Equity	16.03	18.63	18.5	16.63	16.56	36.61

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	15.45	18.16	15.33	12.64	13.79	34.82
Net Cash Growth	-1.77%	18.43%	21.27%	-8.29%	-60.41%	-31.58%
Net Cash Per Share	2.81	4.21	16.47	54.78	98.69	254.77
Book Value	13.95	15.78	16.33	13.88	13.42	30.5
Book Value Per Share	2.53	3.66	17.54	60.14	96.10	223.17
Tangible Book Value	13.95	15.78	16.33	13.88	13.42	30.5
Tangible Book Value Per Share	2.53	3.66	17.54	60.14	96.10	223.17

SEC Filings: 10-K · 10-Q